BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
31 results:

  • 1. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
    BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.
    Wang J; Liu F; Ma W; Hu H; Li F
    Langenbecks Arch Surg; 2023 Sep; 408(1):382. PubMed ID: 37770780
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circular RNA SMARCA5 Promotes a Poor prognosis and Radiotherapy Resistance for Patients with Hepatocellular Carcinoma.
    Chang Z; Song Y; Luo F; Yang X; Cai Y; Guo H
    Ann Clin Lab Sci; 2023 Jul; 53(4):573-577. PubMed ID: 37625840
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
    Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
    Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
    Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
    J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China.
    Lan Y; Lu Y; Li J; Hu S; Chen S; Wang Y; Yuan X; Liu H; Wang X; Wu S; Wang L
    Hepatol Commun; 2022 Dec; 6(12):3393-3405. PubMed ID: 36281973
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The impact of primary tumor location on prognosis after colorectal lung metastasectomy.
    Sponholz S; Oguzhan S; Mese M; Schirren M; Kirschbaum A; Schirren J
    Int J Colorectal Dis; 2021 Aug; 36(8):1731-1737. PubMed ID: 33712904
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
    Wang J; Li X
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Prognostic Significance of C-reactive Protein-To-Lymphocyte Ratio in Colorectal liver Metastases.
    Taniai T; Haruki K; Hamura R; Fujiwara Y; Furukawa K; Gocho T; Shiba H; Yanaga K
    J Surg Res; 2021 Feb; 258():414-421. PubMed ID: 33109402
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological and Prognostic Roles of the Expression Levels of the Programmed Cell Death-1 Gene in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Yang J; Zhang W; Zhang Z; Song F; Ding M; Zhao X; Wang W; Yang Y
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):641-648. PubMed ID: 32990474
    [No Abstract]    [Full Text] [Related]  

  • 11. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
    Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
    Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lower mean platelet volume is a risk indicator of hepatocellular carcinoma recurrence following liver transplantation.
    Zhang AB; Zhang ZH; Zhang J; Lin BY; Geng L; Yang Z; Feng XN; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):223-227. PubMed ID: 31056483
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns.
    Nierop PMH; Galjart B; Höppener DJ; van der Stok EP; Coebergh van den Braak RRJ; Vermeulen PB; Grünhagen DJ; Verhoef C
    Clin Exp Metastasis; 2019 Apr; 36(2):109-118. PubMed ID: 30843120
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.
    Alexandraki KI; Pizanias M; Uri I; Thomas D; Page T; Kolomodi D; Low CS; Adesanya O; Tsoli M; Gross DJ; Randeva H; Srirajaskanthan R; Grozinsky-Glasberg S; Kaltsas G; Weickert MO
    Endocrine; 2019 Jun; 64(3):690-701. PubMed ID: 30635793
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
    Brichler S; Nahon P; Zoulim F; Layese R; Bourcier V; Audureau E; Sutton A; Letouze E; Cagnot C; Marcellin P; Guyader D; Roulot D; Pol S; de Ledinghen V; Zarski JP; Calès P; Tran A; Peron JM; Mallat A; Riachi G; Grange JD; Blanc JF; Bacq Y; Ouzan D; Bronowicki JP; Mathurin P; Larrey D; Alric L; Attali P; Serfaty L; Pilette C; Bourlière M; Thabut D; Silvain C; Wartelle C; Zucman D; Christidis C; Roudot-Thoraval F; Ganne-Carrie N;
    J Viral Hepat; 2019 Mar; 26(3):384-396. PubMed ID: 30380181
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
    Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of ultrasonography-guided percutaneous microwave ablation for subcapsular and nonsubcapsular hepatocellular carcinoma.
    Liu F; Yu X; Cheng Z; Han Z; Sun Y; Liang P; Zhou F
    Eur J Radiol; 2017 Jun; 91():93-98. PubMed ID: 28629577
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    Takamoto T; Sugawara Y; Hashimoto T; Shimada K; Inoue K; Maruyama Y; Makuuchi M
    J Surg Oncol; 2016 Mar; 113(4):463-8. PubMed ID: 27100029
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
    Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
    Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.